These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 7656661)

  • 21. Unorthodox antibiotic combinations including ciprofloxacin against high-level gentamicin resistant enterococci.
    Tripodi MF; Utili R; Rambaldi A; Locatelli A; Rosario P; Florio A; Ruggiero G
    J Antimicrob Chemother; 1996 Apr; 37(4):727-36. PubMed ID: 8722538
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Methodological variation in antibiotic synergy tests against enterococci.
    Ryan RW; Kwasnik I; Tilton RC
    J Clin Microbiol; 1981 Jan; 13(1):73-5. PubMed ID: 6780605
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Daptomycin synergy with rifampicin and ampicillin against vancomycin-resistant enterococci.
    Rand KH; Houck H
    J Antimicrob Chemother; 2004 Mar; 53(3):530-2. PubMed ID: 14963062
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antimicrobial susceptibility patterns of common and unusual species of enterococci causing infections in the United States. Enterococcal Study Group.
    Gordon S; Swenson JM; Hill BC; Pigott NE; Facklam RR; Cooksey RC; Thornsberry C; Jarvis WR; Tenover FC
    J Clin Microbiol; 1992 Sep; 30(9):2373-8. PubMed ID: 1401001
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characterization of high-level aminoglycoside-resistant enterococci in Kuwait hospitals.
    Udo EE; Al-Sweih N; John P; Jacob LE; Mohanakrishnan S
    Microb Drug Resist; 2004; 10(2):139-45. PubMed ID: 15256029
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Aminoglycoside-resistant enterococci.
    Basker MJ; Slocombe B; Sutherland R
    J Clin Pathol; 1977 Apr; 30(4):375-80. PubMed ID: 404337
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [In vitro susceptibility of Enterococcus strains to high level aminoglycosides and heavy metals].
    Nakipoğlu Y; Gümüş D; Sertel Selale D; Küçüker MA
    Mikrobiyol Bul; 2009 Oct; 43(4):545-51. PubMed ID: 20084907
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antimicrobial resistance of Enterococci in Lebanon.
    Zouain MG; Araj GF
    Int J Antimicrob Agents; 2001 Mar; 17(3):209-13. PubMed ID: 11282266
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Resistance to six aminoglycosidic aminocyclitol antibiotics among enterococci: prevalence, evolution, and relationship to synergism with penicillin.
    Calderwood SA; Wennersten C; Moellering RC; Kunz LJ; Krogstad DJ
    Antimicrob Agents Chemother; 1977 Sep; 12(3):401-5. PubMed ID: 242911
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Detection of antibiotic resistance in Enterococcus sp. Comparison of GPS-TA (BioMérieux-Vitek), Uniscept MIC-3 (bioMérieux-Vitek) and conventional methods].
    Alamo I; González A
    Enferm Infecc Microbiol Clin; 1995 Nov; 13(9):516-21. PubMed ID: 8519833
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fractional maximal effect method for in vitro synergy between amoxicillin and ceftriaxone and between vancomycin and ceftriaxone against Enterococcus faecalis and penicillin-resistant Streptococcus pneumoniae.
    Desbiolles N; Piroth L; Lequeu C; Neuwirth C; Portier H; Chavanet P
    Antimicrob Agents Chemother; 2001 Dec; 45(12):3328-33. PubMed ID: 11709304
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synergy of penicillin-netilmicin combinations against enterococci including strains highly resistant to streptomycin or kanamycin.
    Sanders CC
    Antimicrob Agents Chemother; 1977 Aug; 12(2):195-200. PubMed ID: 242509
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synergy of imipenem or penicillin G and aminoglycosides against enterococci isolated from patients with infective endocarditis.
    Indrelie JA; Wilson WR; Matsumoto JY; Geraci JE; Washington JA
    Antimicrob Agents Chemother; 1984 Dec; 26(6):909-12. PubMed ID: 6596907
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevalence of vancomycin and high level aminoglycoside resistant enterococci among high-risk patients.
    Moaddab SR; Rafi A
    Southeast Asian J Trop Med Public Health; 2003 Dec; 34(4):849-54. PubMed ID: 15115099
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A comparison of high-level aminoglycoside resistance in vancomycin-sensitive and vancomycin-resistant Enterococcus species.
    Yazgi H; Ertek M; Erol S; Ayyildiz A
    J Int Med Res; 2002; 30(5):529-34. PubMed ID: 12449524
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Flow cytometric determination of Enterococcus spp. susceptibility to four antimicrobial agents.
    Dolganiuc A; Pană M; Ghiţă M; Stăvaru C; Olinescu A
    Roum Arch Microbiol Immunol; 2001; 60(4):307-22. PubMed ID: 12561673
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synergism with aminoglycosides of penicillin, ampicillin and vancomycin against non-enterococcal group-D streptococci and viridans streptococci.
    Watanakunakorn C; Glotzbecker C
    J Med Microbiol; 1977 Feb; 10(1):133-8. PubMed ID: 584243
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Aminoglycoside-inactivating enzymes in clinical isolates of Streptococcus faecalis. An explanation for resistance to antibiotic synergism.
    Krogstad DJ; Korfhagen TR; Moellering RC; Wennersten C; Swartz MN
    J Clin Invest; 1978 Aug; 62(2):480-6. PubMed ID: 97312
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Detection of high-level aminoglycoside resistance in enterococci other than Enterococcus faecalis.
    Sahm DF; Boonlayangoor S; Schulz JE
    J Clin Microbiol; 1991 Nov; 29(11):2595-8. PubMed ID: 1774267
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Resistance to antibiotics in clinical isolates of the genus Enterococcus].
    Martín MG; De Miguel I; Cañas A; Sánchez AM
    Rev Esp Quimioter; 2000 Dec; 13(4):412-6. PubMed ID: 11498710
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.